Mirae Asset Global Etfs Holdings Ltd. Immunome Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Immunome Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 44,093 shares of IMNM stock, worth $545,871. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,093
Previous 46,821
5.83%
Holding current value
$545,871
Previous $315,000
30.16%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding IMNM
# of Institutions
148Shares Held
66.5MCall Options Held
44.9KPut Options Held
4.24M-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.28MShares$102 Million0.05% of portfolio
-
Redmile Group, LLC San Francisco, CA4.87MShares$60.3 Million5.51% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.69MShares$58 Million0.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.52MShares$56 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.08MShares$50.5 Million3.27% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $150M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...